Potential clinical significance of a plasma-based KRAS mutation analysis in patients with advanced non-small cell lung cancer.
Wang S, An T, Wang J, Zhao J, Wang Z, Zhuo M, Bai H, Yang L, Zhang Y, Wang X, Duan J, Wang Y, Guo Q, Wu M.
Wang S, et al. Among authors: wang x, wang j, wang z, wang y.
Clin Cancer Res. 2010 Feb 15;16(4):1324-30. doi: 10.1158/1078-0432.CCR-09-2672. Epub 2010 Feb 9.
Clin Cancer Res. 2010.
PMID: 20145159